Underactive Bladder
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
AstellasChina - Shenyang
2 programs1
ASP8302Phase 21 trial
Direct Bladder Wall StimulationN/A
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
AstellasASP8302
iota BiosciencesDirect Bladder Wall Stimulation
Clinical Trials (2)
Total enrollment: 150 patients across 2 trials
A Study of ASP8302 in Participants With Underactive Bladder
Start: Nov 2018Est. completion: Apr 2020135 patients
Phase 2Completed
Akyva First In Human
Start: Sep 2025Est. completion: Sep 202815 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 150 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.